BriaCell Therapeutics Corp.BCTXNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank15
Year-over-Year Change
Year-over-year gross profit growth rate
Percentile
P15
Within normal range
vs 5Y Ago
-4.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -1.54% |
| Q3 2025 | 3.94% |
| Q2 2025 | 1.24% |
| Q1 2025 | -5.63% |
| Q4 2024 | 63.56% |
| Q3 2024 | -1841.64% |
| Q2 2024 | 0.50% |
| Q1 2024 | -0.56% |
| Q4 2023 | -0.69% |
| Q3 2023 | 1.92% |
| Q2 2023 | -0.64% |
| Q1 2023 | -1.99% |
| Q4 2022 | 0.00% |
| Q3 2022 | 100.00% |
| Q2 2022 | 0.19% |
| Q1 2022 | -0.94% |
| Q4 2021 | 0.00% |
| Q3 2021 | 100.00% |
| Q2 2021 | 44.40% |
| Q1 2021 | -0.47% |
| Q4 2020 | 0.32% |
| Q3 2020 | 0.81% |
| Q2 2020 | -0.84% |
| Q1 2020 | 0.11% |
| Q4 2019 | 0.47% |
| Q3 2019 | -0.58% |
| Q2 2019 | 0.17% |
| Q1 2019 | 78.23% |
| Q4 2018 | -27.62% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 100.00% |
| Q2 2017 | -1.69% |
| Q1 2017 | -1.72% |
| Q4 2016 | 75.81% |
| Q3 2016 | 0.00% |
| Q2 2016 | 100.00% |
| Q1 2016 | 0.00% |